Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Its strategy is to leverage an asset-rich in-licensing environment, with a focus on utilizing a team with a track record of execution in immunology, inflammation, fibrosis and oncology.
|HQ||San Diego, CA, US||Map|
Net income (Q2, 2021)
EBIT (Q2, 2021)
Market capitalization (23-Sept-2021)
Closing stock price (23-Sept-2021)
|USD||Q3, 2017||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q1, 2021||Q2, 2021|
Depreciation and Amortization
Cash From Operating Activities
Gossamer Bio has 348 Twitter Followers. The number of followers has increased 1.1% month over month and increased 10.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Gossamer Bio founded?
Gossamer Bio was founded in 2015.
Who are Gossamer Bio key executives?
Gossamer Bio's key executives are Bryan Giraudo, Luisa Salter-Cid and Kristina Burow.
How many employees does Gossamer Bio have?
Gossamer Bio has 118 employees.
Who are Gossamer Bio competitors?
Competitors of Gossamer Bio include Silverback Therapeutics, Neovii and SQZ Biotech.
Where is Gossamer Bio headquarters?
Gossamer Bio headquarters is located at 3013 Science Park Rd #200, San Diego.
Where are Gossamer Bio offices?
Gossamer Bio has offices in San Diego and Dublin 2.
How many offices does Gossamer Bio have?
Gossamer Bio has 2 offices.
Receive alerts for 300+ data fields across thousands of companies